Crohn's Disease and Colitis Trial, Recruiting NCT07539727 Sponsor: Nanfang Hospital, Southern Medical University Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Recruiting

NCT07539727
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Crohn's disease, confirmed by a camera examination of the gut (endoscopy) and tissue sample analysis (biopsy), either at this hospital or elsewhere
  • You are between 18 and 70 years old
  • Complete medical and blood test records are available from the week before and after your gut camera examination, including blood counts, liver, kidney, inflammation markers, and other lab results
  • You had a special ultrasound scan of your intestines (color Doppler ultrasound) at the trial hospital within one week before or after your gut camera examination, with full records available
  • Your gut camera examination and other test results show that your Crohn's disease has reached a state of deep remission (meaning the disease is very well controlled, with little or no sign of active inflammation)

Who may not be able to join:

  • You have been diagnosed with bowel or rectal cancer
  • You have serious heart, lung, or kidney problems
  • You are currently pregnant or breastfeeding
  • You are younger than 16 or older than 70 years old (confirm with trial site, as the inclusion criteria states 18–70)
  • You changed your ongoing treatment plan after reaching deep remission
  • Your medical records are incomplete — for example, if the intestinal ultrasound records are missing

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Nanfang Hospital, Southern Medical University
Registry
ClinicalTrials.gov
Start date
1 January 2025
Est. completion
31 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Clinical Recurrence of Crohn's Disease

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov